Mecwins is pleased to announce the filing of a European patent application with the European Patent Office (EPO). The application, which represents a significant advance in biosensor technology, protects a disruptive method for the simultaneous detection of protein and genomic biomarkers.
The development of this technology was made possible through a collaborative effort with DestiNA Genomica SL, whose contributions were instrumental in the invention’s creation. This patent further demonstrates Mecwins’ unwavering commitment to innovation and leadership in the biotechnology sector.
